Mitochondrial DNA sequence variation associated with dementia and cognitive function in the elderly

Journal of Alzheimer's Disease

Volumn 32, Issue 2, 2012, Pages 357-372

  Tranah, Gregory J ^a   Nalls, Michael A ^b   Katzman, Shana M ^c   Yokoyama, Jennifer S ^d   Lam, Ernest T ^a   Zhao, Yiqiang ^c   Mooney, Sean ^c   Thomas, Fridtjof ^e   Newman, Anne B ^f   Liu, Yongmei ^g   Cummings, Steven R ^a   Harris, Tamara B ^b   Yaffe, Kristine ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^g WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cognitive function; dementia; DNA sequencing; mitochondria; mtDNA; oxidative phosphorylation

Indexed keywords

MITOCHONDRIAL DNA;

AGED; ARTICLE; COGNITION; CONTROLLED STUDY; DEMENTIA; DIGIT SYMBOL SUBSTITUTION TEST; DNA SEQUENCE; FEMALE; FOLLOW UP; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MODIFIED MINI MENTAL STATE EXAMINATION; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 84867516927     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120466     Document Type: Article

References (172)

1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA (2003) Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Arch Neurol 60, 1119- 1122.
2. Bishop NA, Lu T, Yankner BA (2010) Neural mechanisms of ageing and cognitive decline. Nature 464, 529-535.
3. Gibson GE, ShiQ(2010)Amitocentric viewof Alzheimer's disease suggests multi-faceted treatments. J Alzheimers Dis 20(SUPPL2 S591-S607
4. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, SmithMA(2001) Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60, 759-767.
5. Coskun PE, Wyrembak J, Derbereva O, Melkonian G, Doran E, Lott IT, Head E, Cotman CW, Wallace DC (2010) Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia. J Alzheimers Dis 20(SUPPL2 S293-S310
6. Hirai K, Aliev G, Nunomura A, Fujioka H, Russell RL, Atwood CS, Johnson AB, Kress Y, Vinters HV, Tabaton M, Shimohama S, Cash AD, Siedlak SL, Harris PL, Jones PK, Petersen RB, Perry G, SmithMA(2001) Mitochondrial abnormalities in Alzheimer's disease. J Neurosci 21, 3017- 3023.
7. Pratico D, Clark CM, Liun F, Rokach J, Lee VY, Trojanowski JQ (2002) Increase of brain oxidative stress in mild cognitive impairment: A possible predictor of Alzheimer disease. Arch Neurol 59, 972-976.
8. Arlt S, Beisiegel U, Kontush A (2002) Lipid peroxidation in neurodegeneration: New insights into Alzheimer's disease. urr Opin Lipidol 13, 289-294.
9. Harris ME, Hensley K, Butterfield DA, Leedle RA, Carney JM(1995) Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons. Exp Neurol 131, 193-202.
10. Lovell MA, Xie C, Gabbita SP, Markesbery WR (2000) Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. Free Radic Biol Med 28, 418-427.
11. Pocernich CB, Butterfield DA (2003) Acrolein inhibits NADH-linked mitochondrial enzyme activity: Implications for Alzheimer's disease. Neurotox Res 5, 515-520.
12. Yao Y, Zhukareva V, Sung S, Clark CM, Rokach J, Lee VM, Trojanowski JQ, Pratico D (2003) Enhanced brain levels of 8,12-iso-iPF2alpha-VI differentiate AD from frontotemporal dementia. Neurology 61, 475-478.
13. Chinopoulos C, Tretter L, Adam-Vizi V (1999) Depolarization of in situ mitochondria due to hydrogen peroxide-induced oxidative stress in nerve terminals: Inhibition of alpha-ketoglutarate dehydrogenase. J Neurochem 73, 220-228.
14. Park LC, Zhang H, Sheu KF, Calingasan NY, Kristal BS, Lindsay JG, Gibson GE (1999) Metabolic impairment induces oxidative stress, compromises inflammatory responses, and inactivates a key mitochondrial enzyme in microglia. J Neurochem 72, 1948-1958.
15. Gibson GE, Zhang H, Sheu KR, Park LC (2000) Differential alterations in antioxidant capacity in cells from Alzheimer patients. Biochim Biophys Acta 1502, 319-329.
16. Nulton-Persson AC, Starke DW, Mieyal JJ, Szweda LI (2003) Reversible inactivation of alpha-ketoglutarate dehydrogenase in response to alterations in the mitochondrial glutathione status. Biochemistry 42, 4235- 4242.
17. Humphries KM, Szweda LI (1998) Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: Reaction of lipoic acid with 4-hydroxy-2-nonenal. Biochemistry 37, 15835-15841.
18. Rokutan K, Kawai K, Asada K (1987) Inactivation of 2- oxoglutarate dehydrogenase in rat liver mitochondria by its substrate and t-butyl hydroperoxide. J Biochem 101, 415- 422.
19. Correa JG, Stoppani AO (1996) Catecholamines enhance dihydrolipoamide dehydrogenase inactivation by the copper Fenton system. Enzyme protection by copper chelators. Free Radic Res 24, 311-322.
20. Hinerfeld D, Traini MD, Weinberger RP, Cochran B, Doctrow SR, Harry J, Melov S (2004) Endogenous mitochondrial oxidative stress: Neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice. J Neurochem 88, 657-667.
21. Pruijn FB, Schoonen WG, Joenje H (1992) Inactivation of mitochondrial metabolism by hyperoxia-induced oxidative stress. Ann N Y Acad Sci 663, 453-455.
22. Schoonen WG, Wanamarta AH, van der Klei-van Moorsel JM, Jakobs C, Joenje H (1991) Characterization of oxygenresistant Chinese hamster ovary cells. III. Relative resistance of succinate and alpha-ketoglutarate dehydrogenases to hyperoxic inactivation. Free Radic Biol Med 10, 111-118.
23. Shi Q, Xu H, KleinmanWA, Gibson GE (2008) Novel functions of the alpha-ketoglutarate dehydrogenase complex may mediate diverse oxidant-induced changes in mitochondrial enzymes associated with Alzheimer's disease. Biochim Biophys Acta 1782, 229-238.
24. Gabuzda D, Busciglio J, Chen LB, Matsudaira P, Yankner BA (1994) Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J Biol Chem 269, 13623-13628.
25. O'Connor T, Sadleir KR, Maus E, Velliquette RA, Zhao J, Cole SL, Eimer WA, Hitt B, Bembinster LA, Lammich S, Lichtenthaler SF, Hebert SS, De Strooper B, Haass C, Bennett DA, Vassar R (2008) Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 60, 988-1009.
26. Tamagno E, Bardini P, Obbili A,Vitali A, Borghi R, Zaccheo D, Pronzato MA, Danni O, Smith MA, Perry G, Tabaton M (2002) Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis 10, 279-288.
27. Tamagno E, Guglielmotto M, Aragno M, Borghi R, Autelli R, Giliberto L, Muraca G, Danni O, Zhu X, Smith MA, Perry G, Jo DG, Mattson MP, Tabaton M (2008) Oxidative stress activates a positive feedback between the gamma- And betasecretase cleavages of the beta-amyloid precursor protein. J Neurochem 104, 683-695.
28. Tong Y, ZhouW, Fung V, Christensen MA, Qing H, Sun X, Song W (2005) Oxidative stress potentiates BACE1 gene expression and Abeta generation. J Neural Transm 112, 455- 469.
29. CalingasanNY, Uchida K, GibsonGE(1999) Protein-bound acrolein: A novel marker of oxidative stress in Alzheimer's disease. J Neurochem 72, 751-756.
30. Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M, Leuner K, Eckert A, Muller WE (2009) Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging 30, 1574-1586.
31. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 106, 14670- 14675.
32. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102.
33. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH (2006) Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: Implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15, 1437-1449.
34. Mucke L, Masliah E, Yu GQ, Mallory M, Rockenstein EM, Tatsuno G, Hu K, Kholodenko D, Johnson-Wood K, McConlogue L (2000) High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: Synaptotoxicity without plaque formation. J Neurosci 20, 4050-4058.
35. Pratico D, Uryu K, Leight S, Trojanoswki JQ, Lee VM (2001) Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J Neurosci 21, 4183-4187.
36. Leuner K, Schutt T, Kurz C, Eckert SH, Schiller C, Occhipinti A, Mai S, Jendrach M, Eckert GP, Kruse SE, Palmiter RD, Brandt U, Drose S, Wittig I, Willem M, Haass C, Reichert AS, Mueller WE (2012) Mitochondria-derived ROS lead to enhanced amyloid beta formation. Antioxid Redox Signal 16, 1421-1433.
37. de la Monte SM, Luong T, Neely TR, Robinson D, Wands JR (2000) Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease. Lab Invest 80, 1323-1335.
38. Anglade P, Vyas S, Hirsch EC, Agid Y (1997) Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging. Histol Histopathol 12, 603-610.
39. Dragicevic N, Mamcarz M, Zhu Y, Buzzeo R, Tan J, ArendashGW, BradshawPC (2010) Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. J Alzheimers Dis 20(SUPPL2 S535-S550.
40. de Grey AD (1997) A proposed refinement of the mitochondrial free radical theory of aging. Bioessays 19, 161-166.
41. Gibson GE, Huang HM (2004) Mitochondrial enzymes and endoplasmic reticulum calcium stores as targets of oxidative stress in neurodegenerative diseases. J Bioenerg Biomembr 36, 335-340.
42. Haces ML, Montiel T, Massieu L (2010) Selective vulnerability of brain regions to oxidative stress in a non-coma model of insulin-induced hypoglycemia. Neuroscience 165, 28-38.
43. Eckert A, Keil U, Marques CA, Bonert A, Frey C, Schussel K, Muller WE (2003) Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochem Pharmacol 66, 1627-1634.
44. Blass JP, Gibson GE, Hoyer S (2002) The role of the metabolic lesion in Alzheimer's disease. J Alzheimers Dis 4, 225-232.
45. Grazina M, Pratas J, Silva F, Oliveira S, Santana I, Oliveira C (2006) Genetic basis of Alzheimer's dementia: Role of mtDNA mutations. Genes Brain Behav 5(SUPPL2 pag 92-107.
46. Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, Cash AD, Obrenovich ME, Perry G, Smith MA (2002) Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res 70, 357-360.
47. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, McKee AC, Beal MF, Graham BH, Wallace DC (1994) Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 23, 471-476.
48. Wallace DC (2010) Colloquium paper: Bioenergetics, the origins of complexity, and the ascent of man. Proc Natl Acad Sci U S A 107(SUPPL2 8947-8953.
49. Brown MD, Wallace DC (1994) Molecular basis of mitochondrial DNA disease. J Bioenerg Biomembr 26, 273-289.
50. De Vivo DC (1993) The expanding clinical spectrum of mitochondrial diseases. Brain Dev 15, 1-22.
51. Graeber MB, Grasbon-Frodl E, Eitzen UV, Kosel S (1998) Neurodegeneration and aging: Role of the second genome. J Neurosci Res 52, 1-6.
52. Wallace DC (2001) A mitochondrial paradigm for degenerative diseases and ageing. Novartis Found Symp 235, 247-263; discussion 263-246.
53. HutchinTP, Heath PR, Pearson RC, Sinclair AJ (1997) Mitochondrial DNA mutations in Alzheimer's disease. Biochem Biophys Res Commun 241, 221-225.
54. Manczak M, Park BS, JungY, Reddy PH (2004) Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: Implications for early mitochondrial dysfunction and oxidative damage. Neuromolecular Med 5, 147-162.
55. Bowling AC, Mutisya EM, Walker LC, Price DL, Cork LC, Beal MF (1993) Age-dependent impairment of mitochondrial function in primate brain. J Neurochem 60, 1964-1967.
56. Jazin EE, Cavelier L, Eriksson I, Oreland L, Gyllensten U (1996) Human brain contains high levels of heteroplasmy in the noncoding regions of mitochondrial DNA. Proc Natl Acad Sci U S A 93, 12382-12387.
57. Arnheim N, Cortopassi G (1992) Deleterious mitochondrial DNA mutations accumulate in aging human tissues. Mutat Res 275, 157-167.
58. Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS, Betts J, Klopstock T, Taylor RW, Turnbull DM (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38, 515-517.
59. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC (1992) Mitochondrial DNA deletions in human brain: Regional variability and increase with advanced age. Nat Genet 2, 324-329.
60. KraytsbergY,Kudryavtseva E,McKeeAC, Geula C,Kowall NW, Khrapko K (2006) Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 38, 518-520.
61. Reeve AK, Krishnan KJ, Elson JL, Morris CM, Bender A, Lightowlers RN, Turnbull DM (2008) Nature of mitochondrial DNA deletions in substantia nigra neurons. Am J Hum Genet 82, 228-235.
62. Soong NW, Hinton DR, Cortopassi G, Arnheim N (1992) Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nat Genet 2, 318-323.
63. Chinnery PF, Taylor GA, Howell N, Brown DT, Parsons TJ, Turnbull DM (2001) Point mutations of the mtDNA control region in normal and neurodegenerative human brains. Am J Hum Genet 68, 529-532.
64. Niemi AK, Moilanen JS, Tanaka M, Hervonen A, Hurme M, Lehtimaki T, Arai Y, Hirose N, Majamaa K (2005) A combination of three common inherited mitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects. Eur J Hum Genet 13, 166-170.
65. Brand MD (2010) The sites and topology of mitochondrial superoxide production. Exp Gerontol 45, 466-472.
66. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, Robinson JP (2003) Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 278, 8516-8525.
67. Tarnopolsky MA, Simon DK, Roy BD, Chorneyko K, Lowther SA, Johns DR, Sandhu JK, LiY, SikorskaM(2004) Attenuation of free radical production and paracrystalline inclusions by creatine supplementation in a patient with a novel cytochrome b mutation. Muscle Nerve 29, 537-547.
68. Migliore L, Fontana I, Trippi F, Colognato R, Coppede F, Tognoni G, Nucciarone B, Siciliano G (2005) Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol Aging 26, 567-573.
69. Itoh K, Weis S, Mehraein P, Muller-Hocker J (1996) Cytochrome c oxidase defects of the human substantia nigra in normal aging. Neurobiol Aging 17, 843-848.
70. Lin FH, Lin R, Wisniewski HM, Hwang YW, Grundke- Iqbal I, Healy-Louie G, Iqbal K (1992) Detection of point mutations in codon 331 of mitochondrial NADH dehydrogenase subunit 2 in Alzheimer's brains. Biochem Biophys Res Commun 182, 238-246.
71. Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, Mirra SS, Beal MF, Yang CC, Gearing M, Salvo R et al. (1993) Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17, 171- 184.
72. Hutchin T, CortopassiG(1995)AmitochondrialDNAclone is associated with increased risk for Alzheimer disease. Proc Natl Acad Sci U S A 92, 6892-6895.
73. Egensperger R, Kosel S, Schnopp NM, Mehraein P, Graeber MB (1997) Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases. Neuropathol Appl Neurobiol 23, 315-321.
74. Edland SD, Silverman JM, Peskind ER, Tsuang D,Wijsman E, Morris JC (1996) Increased risk of dementia in mothers of Alzheimer's disease cases: Evidence for maternal inheritance. Neurology 47, 254-256.
75. Grazina M, Silva F, Santana I, Pratas J, Santiago B, Oliveira M, Carreira I, Cunha L, Oliveira C (2005) Mitochondrial DNA variants in a portuguese population of patients with Alzheimer's disease. Eur Neurol 53, 121-124.
76. Qiu X, Chen Y, Zhou M (2001) Two point mutations in mitochondrial DNA of cytochrome c oxidase coexist with normal mtDNA in a patient with Alzheimer's disease. Brain Res 893, 261-263.
77. Tanno Y, Okuizumi K, Tsuji S (1998) mtDNA polymorphisms in Japanese sporadic Alzheimer's disease. Neurobiol Aging 19, S47-S51.
78. Brown MD, Shoffner JM, Kim YL, Jun AS, Graham BH, Cabell MF, Gurley DS, Wallace DC (1996) Mitochondrial DNAsequence analysis of four Alzheimer's and Parkinson's disease patients. Am J Med Genet 61, 283-289.
79. Edland SD,TobeVO, Rieder MJ,Bowen JD, McCormickW, Teri L, Schellenberg GD, Larson EB, NickersonDA,Kukull WA (2002) Mitochondrial genetic variants and Alzheimer disease: A case-control study of the T4336C and G5460A variants. Alzheimer Dis Assoc Disord 16, 1-7.
80. Kosel S, Egensperger R, Mehraein P, GraeberMB(1994) No association of mutations at nucleotide 5460 of mitochondrial NADH dehydrogenase with Alzheimer's disease. Biochem Biophys Res Commun 203, 745-749.
81. Petruzzella V, Chen X, Schon EA (1992) Is a point mutation in the mitochondrial ND2 gene associated withAlzheimer's disease. Biochem Biophys Res Commun 186, 491-497.
82. Wragg MA, Talbot CJ, Morris JC, Lendon CL, Goate AM (1995) No association found between Alzheimer's disease and a mitochondrial tRNA glutamine gene variant. Neurosci Lett 201, 107-110.
83. Tysoe C, Robinson D, Brayne C, Dening T, Paykel ES, Huppert FA, Rubinsztein DC (1996) The tRNA(Gln) 4336 mitochondrial DNA variant is not a high penetrance mutation which predisposes to dementia before the age of 75 years. J Med Genet 33, 1002-1006.
84. JanetzkyB, Schmid C, Bischof F, Frolich L, GsellW, Kalaria RN, Riederer P, Reichmann H (1996) Investigations on the point mutations at nt 5460 of the mtDNA in different neurodegenerative and neuromuscular diseases. Eur Neurol 36, 149-153.
85. Wallace DC, Stugard C, Murdock D, Schurr T, Brown MD (1997) Ancient mtDNA sequences in the human nuclear genome: A potential source of errors in identifying pathogenic mutations. Proc Natl Acad Sci U S A 94, 14900-14905.
86. Neckelmann N, Li K, Wade RP, Shuster R, Wallace DC (1987) cDNA sequence of a human skeletal muscle ADP/ATP translocator: Lack of a leader peptide, divergence from a fibroblast translocator cDNA, and coevolution with mitochondrial DNA genes. Proc Natl Acad Sci U S A 84, 7580-7584.
87. Merriwether DA, Clark AG, Ballinger SW, Schurr TG, Soodyall H, Jenkins T, Sherry ST, Wallace DC (1991) The structure of human mitochondrialDNAvariation. J Mol Evol 33, 543-555.
88. Wallace DC, Fan W, Procaccio V (2010) Mitochondrial energetics and therapeutics. Annu Rev Pathol 5, 297-348.
89. Rooks RN, Simonsick EM, Miles T, Newman A, Kritchevsky SB, Schulz R, Harris T (2002) The association of race and socioeconomic status with cardiovascular disease indicators among older adults in the health, aging, and body composition study. J Gerontol B Psychol Sci Soc Sci 57, S247-S256.
90. Teng EL, Chui HC (1987) The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48, 314-318.
91. Wechsler D (1981) Wechsler Adult Intelligence Scale - Revised, San Antonio, Psychological Corporation.
92. Beres CA, Baron A (1981) Improved digit symbol substitution by older women as a result of extended practice. J Gerontol 36, 591-597.
93. Tierney MC, SnowWG, Reid DW, Zorzitto ML, Fisher RH (1987) Psychometric differentiation of dementia. Replication and extension of the findings of Storandt and coworkers. Arch Neurol 44, 720-722.
94. Fiocco AJ, Lindquist K, Ferrell R, Li R, Simonsick EM, Nalls M, Harris TB, Yaffe K (2010) COMT genotype and cognitive function: An 8-year longitudinal study in white and black elders. Neurology 74, 1296-1302.
95. Saxena R, de Bakker PI, Singer K, Mootha V, Burtt N, Hirschhorn JN, Gaudet D, Isomaa B, Daly MJ, Groop L, Ardlie KG, Altshuler D (2006) Comprehensive association testing of common mitochondrial DNA variation in metabolic disease. Am J Hum Genet 79, 54-61.
96. Tranah GJ, Manini TM, Lohman KK, Nalls MA, Kritchevsky S,Newman AB, Harris TB, Miljkovic I, BiffiA, Cummings SR, Liu Y (2011) Mitochondrial DNA variation in human metabolic rate and energy expenditure. Mitochondrion 11, 855-861.
97. van Oven M, Kayser M (2009) Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat 30, E386-E394.
98. Manini TM, Everhart JE, Patel KV, Schoeller DA, Colbert LH,VisserM,Tylavsky F, Bauer DC, Goodpaster BH, Harris TB (2006) Daily activity energy expenditure and mortality among older adults. JAMA 296, 171-179.
99. Lam ET, Bracci PM, Holly EA, Chu C, Poon A, Wan E, White K,KwokPY, Pawlikowska L,Tranah GJ (2012) Mitochondrial DNA sequence variation and risk of pancreatic cancer. Cancer Res 72, 686-695.
100. Symons S, Weber K, Bonin M, Nieselt K (2008) ResqMi - A versatile algorithm and software for resequencing microarrays. In Proceedings of the German Conference on Bioinformatics,Vol 136, Beyer A, SchroederM(Eds). Dresden, Germany, 136, pp. 10-20.
101. Price AL, Patterson NJ, Plenge RM,Weinblatt ME, Shadick NA, Reich D (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38, 904-909.
102. Price AL, Zaitlen NA, Reich D, Patterson N (2010) New approaches to population stratification in genome-wide association studies. Nat Rev Genet 11, 459-463.
103. Reich D, Price AL, Patterson N (2008) Principal component analysis of genetic data. Nat Genet 40, 491-492.
104. Patterson N, Price AL, Reich D (2006) Population structure and eigenanalysis. PlosGenet 2, e190.
105. Biffi A, Anderson CD, Nalls MA, Rahman R, Sonni A, Cortellini L, Rost NS, Matarin M, Hernandez DG, Plourde A, de Bakker PI, Ross OA, Greenberg SM, Furie KL, Meschia JF, Singleton AB, Saxena R, Rosand J (2010) Principal-component analysis for assessment of population stratification in mitochondrial medical genetics. Am J Hum Genet 86, 904-917.
106. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, Clawson H, Spieth J, Hillier LW, Richards S, Weinstock GM, Wilson RK, Gibbs RA, Kent WJ, Miller W, Haussler D (2005) Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 15, 1034-1050.
107. Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A (2010) Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res 20, 110-121.
108. Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4, 1073-1081.
109. Ng PC, Henikoff S (2006) Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet 7, 61-80.
110. Li B, Krishnan VG, Mort ME, Xin F, Kamati KK, Cooper DN, Mooney SD, Radivojac P (2009) Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics 25, 2744-2750.
111. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7, 248-249.
112. VT test http://genetics.bwh.harvard.edu/vt/dokuwiki/start.
113. Li B, Leal SM (2008) Methods for detecting associations with rare variants for common diseases: Application to analysis of sequence data. Am J Hum Genet 83, 311-321.
114. Madsen BE, Browning SR (2009) A groupwise association test for rare mutations using a weighted sum statistic. PlosGenet 5, e1000384.
115. Price AL, Kryukov GV, de Bakker PI, Purcell SM, Staples J, Wei LJ, Sunyaev SR (2010) Pooled association tests for rare variants in exon-resequencing studies. Am J Hum Genet 86, 832-838.
116. Lam ET, Bracci PM, Holly EA, Chu C, Poon A, Wan E, White K,KwokPY, Pawlikowska L,Tranah GJ (2012) Mitochondrial DNA sequence variation and risk of pancreatic cancer. Cancer Res 72, 686-695.
117. Coon KD, Valla J, Szelinger S, Schneider LE, Niedzielko TL, Brown KM, Pearson JV, Halperin R, Dunckley T, Papassotiropoulos A, Caselli RJ, Reiman EM, StephanDA(2006) Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing. Mitochondrion 6, 194-210.
118. Maitra A, Cohen Y, Gillespie SE, Mambo E, Fukushima N, Hoque MO, Shah N, Goggins M, Califano J, Sidransky D, Chakravarti A (2004) The Human MitoChip: A high-throughput sequencing microarray for mitochondrial mutation detection. Genome Res 14, 812-819.
119. Chinnery PF, Taylor GA, Howell N, Andrews RM, Morris CM, Taylor RW, McKeith IG, Perry RH, Edwardson JA, Turnbull DM (2000) Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology 55, 302-304.
120. van der Walt JM, Scott WK, Slifer S, Gaskell PC, Martin ER, Welsh-Bohmer K, Creason M, Crunk A, Fuzzell D, McFarland L, Kroner CC, Jackson CE, Haines JL, Pericak- Vance MA (2005) Maternal lineages and Alzheimer disease risk in the Old Order Amish. Hum Genet 118, 115-122.
121. Suissa S, Wang Z, Poole J, Wittkopp S, Feder J, Shutt TE, Wallace DC, Shadel GS, MishmarD(2009) AncientmtDNA genetic variants modulate mtDNA transcription and replication. PlosGenet 5, e1000474.
122. Niemi AK, Hervonen A, Hurme M, Karhunen PJ, Jylha M, Majamaa K (2003) Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum Genet 112, 29-33.
123. Ross OA, McCormack R, Curran MD, Duguid RA, Barnett YA, Rea IM, Middleton D (2001) Mitochondrial DNA polymorphism: Its role in longevity of the Irish population. Exp Gerontol 36, 1161-1178.
124. De Benedictis G, Rose G, Carrieri G, De Luca M, Falcone E, Passarino G, Bonafe M, Monti D, Baggio G, Bertolini S, Mari D, Mattace R, Franceschi C (1999) Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. FASEB J 13, 1532-1536.
125. Bodmer W, Bonilla C (2008) Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 40, 695-701.
126. Frazer KA, Murray SS, Schork NJ, Topol EJ (2009) Human genetic variation and its contribution to complex traits. Nat Rev Genet 10, 241-251.
127. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TF, McCarroll SA, Visscher PM (2009) Finding the missing heritability of complex diseases. Nature 461, 747-753.
128. Schork NJ, Murray SS, Frazer KA, Topol EJ (2009) Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 19, 212-219.
129. Altshuler D, Daly MJ, Lander ES (2008) Genetic mapping in human disease. Science 322, 881-888.
130. Quinlan CL, Gerencser AA, Treberg JR, Brand MD (2011) The mechanism of superoxide production by the antimycininhibited mitochondrial Q-cycle. J Biol Chem 286, 31361- 31372.
131. Tranah GJ, Lam ET, Katzman SM, Nalls MA, ZhaoY, Evans DS, Yokoyama JS, Pawlikowska L, Kwok PY, Mooney S, Kritchevsky S, Goodpaster BH, Newman AB, Harris TB, Manini TM, Cummings SR (2012) Mitochondrial DNA sequence variation is associated with free-living activity energy expenditure in the elderly. Biochim Biophys Acta 1817, 1691-1700.
132. Bolanos JP, Almeida A (2007) Nitric oxide in regulation of mitochondrial function, respiration, and glycolysis. In Handbook of Neurochemistry and Molecular Biology, 3rd edition, Gibson GE, Dienel G (Eds). Springer, pp. 487-518.
133. Joseph JA, Gibson GE (2007) Coupling of neuronal function to oxygen and glucose metabolism through changes in neurotransmitter dynamics as revealed with aging, hypoglycemia and hypoxia. In Handbook of Neurochemistry and Molecular Biology, 3rd edition, Gibson GE, DienelG(Eds). Springer, pp. 297-320.
134. Patel J, Pathak RR, Mujtaba S (2011) The biology of lysine acetylation integrates transcriptional programming and metabolism. Nutr Metab (Lond) 8, 12.
135. Zhao S, XuW, JiangW, YuW, Lin Y, Zhang T, Yao J, Zhou L, Zeng Y, Li H, Li Y, Shi J, An W, Hancock SM, He F, Qin L, Chin J, Yang P, Chen X, Lei Q, Xiong Y, Guan KL (2010) Regulation of cellular metabolism by protein lysine acetylation. Science 327, 1000-1004.
136. Wang Q, Zhang Y, Yang C, Xiong H, Lin Y, Yao J, Li H, Xie L, Zhao W, Yao Y, Ning ZB, Zeng R, Xiong Y, Guan KL, Zhao S, Zhao GP (2010) Acetylation of metabolic enzymes coordinates carbon source utilization and metabolic flux. Science 327, 1004-1007.
137. Yu W, Lin Y, Yao J, Huang W, Lei Q, Xiong Y, Zhao S, Guan KL (2009) Lysine 88 acetylation negatively regulates ornithine carbamoyltransferase activity in response to nutrient signals. J Biol Chem 284, 13669-13675.
138. Huoponen K, Lamminen T, Juvonen V, Aula P, Nikoskelainen E, Savontaus ML (1993) The spectrum of mitochondrialDNAmutations in families with Leber hereditary optic neuroretinopathy. Hum Genet 92, 379-384.
139. Cai W, Fu Q, Zhou X, Qu J, Tong Y, Guan MX (2008) Mitochondrial variants may influence the phenotypic manifestationof Leber's hereditary optic neuropathy-associated ND4 G11778A mutation. J Genet Genomics 35, 649-655.
140. MITOMAP: A Human Mitochondrial Genome Database, http://www.mitomap.org.
141. Torkamani A, Topol EJ, Schork NJ (2008) Pathway analysis of seven common diseases assessed by genome-wide association. Genomics 92, 265-272.
142. Kathiresan S, Voight BF, Purcell S, Musunuru K, Ardissino D, Mannucci PM, Anand S, Engert JC, Samani NJ, Schunkert H, Erdmann J, Reilly MP, Rader DJ, Morgan T, Spertus JA, Stoll M, Girelli D, McKeown PP, Patterson CC, Siscovick DS, O'Donnell CJ, Elosua R, Peltonen L, Salomaa V, Schwartz SM, Melander O, Altshuler D, Ardissino D, Merlini PA, Berzuini C, Bernardinelli L, Peyvandi F, Tubaro M, Celli P, Ferrario M, Fetiveau R, Marziliano N, Casari G, Galli M, Ribichini F, Rossi M, Bernardi F, Zonzin P, Piazza, Mannucci PM, Schwartz SM, Siscovick DS,Yee J, Friedlander Y, Elosua R, Marrugat J, Lucas G, Subirana I, Sala J, Ramos R, Kathiresan S, Meigs JB,WilliamsG, Nathan DM, MacRae CA, O'Donnell CJ, Salomaa V, Havulinna AS, Peltonen L, Melander O, Berglund G, Voight BF, Kathiresan S, Hirschhorn JN, Asselta R, Duga S, Spreafico M, Musunuru K, Daly MJ, Purcell S,Voight BF, Purcell S, Nemesh J,Korn JM,McCarroll SA, Schwartz SM,Yee J, Kathiresan S, Lucas G, Subirana I, Elosua R, Surti A, Guiducci C, Gianniny L, Mirel D, Parkin M, Burtt N, Gabriel SB, Samani NJ, Thompson JR, Braund PS, Wright BJ, Balmforth AJ, Ball SG, Hall AS, et al. (2009) Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 41, 334-341.
143. Kathiresan S,Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, Kaplan L, Bennett D, Li Y, Tanaka T, Voight BF, Bonnycastle LL, Jackson AU, Crawford G, Surti A, Guiducci C, BurttNP, Parish S, ClarkeR, Zelenika D,Kubalanza KA, Morken MA, Scott LJ, Stringham HM, Galan P, Swift AJ, Kuusisto J, Bergman RN, Sundvall J, Laakso M, Ferrucci L, Scheet P, Sanna S, Uda M, Yang Q, Lunetta KL, Dupuis J, de Bakker PI, O'Donnell CJ, Chambers JC, Kooner JS, Hercberg S, Meneton P, Lakatta EG, Scuteri A, Schlessinger D, Tuomilehto J, Collins FS, Groop L, Altshuler D, Collins R, Lathrop GM, Melander O, Salomaa V, Peltonen L, Orho-Melander M, Ordovas JM, Boehnke M, Abecasis GR, Mohlke KL, Cupples LA (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41, 56-65.
144. Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, Najjar SS, Zhao JH, Heath SC, Eyheramendy S, Papadakis K, Voight BF, Scott LJ, Zhang F, Farrall M, Tanaka T, Wallace C, Chambers JC, Khaw KT, Nilsson P, van der Harst P, Polidoro S, Grobbee DE, Onland-Moret NC, Bots ML, Wain LV, Elliott KS, Teumer A, Luan J, Lucas G, Kuusisto J, Burton PR, Hadley D, McArdle WL, Brown M, Dominiczak A, Newhouse SJ, Samani NJ, Webster J, Zeggini E, Beckmann JS, Bergmann S, Lim N, Song K, Vollenweider P, Waeber G, Waterworth DM, Yuan X, Groop L, Orho-Melander M, Allione A, Di Gregorio A, Guarrera S, Panico S, Ricceri F, Romanazzi V, Sacerdote C, Vineis P, Barroso I, Sandhu MS, Luben RN, Crawford GJ, Jousilahti P, Perola M, Boehnke M, Bonnycastle LL, Collins FS, Jackson AU,Mohlke KL, Stringham HM, Valle TT,Willer CJ, Bergman RN, Morken MA, Doring A, Gieger C, Illig T, Meitinger T, Org E, Pfeufer A, Wichmann HE, Kathiresan S, Marrugat J, O'Donnell CJ, Schwartz SM, Siscovick DS, Subirana I, Freimer NB, Hartikainen AL, McCarthy MI, O'Reilly PF, Peltonen L, Pouta A, de Jong PE, Snieder H, van Gilst WH, Clarke R, Goel A, Hamsten A, Peden JF, Seedorf U, Syvanen AC, Tognoni G, Lakatta EG, Sanna S, Scheet P, Schlessinger D, Scuteri A, Dorr M, Ernst F, Felix SB, Homuth G, Lorbeer R, Reffelmann T, Rettig R, Volker U, Galan P, Gut IG, Hercberg S, Lathrop GM, Zelenika D, Deloukas P, Soranzo N, Williams FM, Zhai G, Salomaa V, Laakso M, Elosua R, Forouhi NG, Volzke H, Uiterwaal CS, van der Schouw YT, Numans ME, Matullo G, Navis G, Berglund G, Bingham SA, Kooner JS, Connell JM, Bandinelli S, Ferrucci L, Watkins H, Spector TD, Tuomilehto J, Altshuler D, Strachan DP, Laan M, Meneton P, Wareham NJ, Uda M, Jarvelin MR, Mooser V, Melander O, Loos RJ, Elliott P, Abecasis GR, Caulfield M, Munroe PB (2009) Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet 41, 666-676.
145. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748-752.
146. Ruiz-Pesini E, Mishmar D, Brandon M, Procaccio V, Wallace DC (2004) Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 303, 223- 226.
147. Lee JW, Park KD, Im JA, Kim MY, Lee DC (2010) Mitochondrial DNA copy number in peripheral blood is associated with cognitive function in apparently healthy elderly women. Clin Chim Acta 411, 592-596.
148. Willett CS, Burton RS (2003) Environmental influences on epistatic interactions: Viabilities of cytochrome c genotypes in interpopulation crosses. Evolution 57, 2286-2292.
149. Rand DM, Clark AG, Kann LM (2001) Sexually antagonistic cytonuclear fitness interactions in Drosophila melanogaster. Genetics 159, 173-187.
150. Rand DM, Fry A, Sheldahl L (2006) Nuclear-mitochondrial epistasis and drosophila aging: Introgression of Drosophila simulans mtDNA modifies longevity in D. melanogaster nuclear backgrounds. Genetics 172, 329-341.
151. Rand DM, Haney RA, Fry AJ (2004) Cytonuclear coevolution: The genomics of cooperation. Trends Ecol Evol 19, 645-653.
152. Rand DM, Kann LM (1998) Mutation and selection at silent and replacement sites in the evolution of animal mitochondrial DNA. Genetica 102-103 393-407.
153. Pravenec M, Hyakukoku M, Houstek J, Zidek V, Landa V, Mlejnek P, Miksik I, Dudova-Mothejzikova K, Pecina P, Vrbacky M, Drahota Z, Vojtiskova A, Mracek T, Kazdova L, Oliyarnyk O, Wang J, Ho C, Qi N, Sugimoto K, Kurtz T (2007) Direct linkage of mitochondrial genome variation to risk factors for type 2 diabetes in conplastic strains. Genome Res 17, 1319-1326.
154. Mishmar D, Ruiz-Pesini E, Mondragon-Palomino M, Procaccio V, Gaut B,Wallace DC (2006) Adaptive selection of mitochondrial complex I subunits during primate radiation. Gene 378, 11-18.
155. Tranah GJ (2011) Mitochondrial-nuclear epistasis: Implications for human aging and longevity. Ageing Res Rev 10, 238-252.
156. Hutter CM, Rand DM (1995) Competition between mitochondrial haplotypes in distinct nuclear genetic environments: Drosophila pseudoobscura vs. D. persimilis. Genetics 140, 537-548.
157. Schmidt TR,WuW, Goodman M, Grossman LI (2001) Evolution of nuclear- And mitochondrial-encoded subunit interaction in cytochrome c oxidase. Mol Biol Evol 18, 563-569.
158. Rawson PD, Burton RS (2002) Functional coadaptation between cytochrome c and cytochrome c oxidase withinallopatric populations of a marine copepod. Proc Natl Acad Sci U S A 99, 12955-12958.
159. DowlingDK,FribergU, Hailer F, ArnqvistG(2007) Intergenomic epistasis for fitness: Within-population interactions between cytoplasmic and nuclear genes in Drosophila melanogaster. Genetics 175, 235-244.
160. Rhode JM, Cruzan MB (2005) Contributions of heterosis and epistasis to hybrid fitness. Am Nat 166, E124-E139.
161. Donati A, Cavallini G, Paradiso C, Vittorini S, Pollera M, Gori Z, Bergamini E (2001) Age-related changes in the regulation of autophagic proteolysis in rat isolated hepatocytes. J Gerontol A Biol Sci Med Sci 56, B288-B293.
162. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, SinclairDA(2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342.
163. Davis JM, Murphy EA, Carmichael MD, Davis B (2009) Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol 296, R1071-R1077.
164. Liu Z, Sun L, Zhu L, Jia X, Li X, Jia H, Wang Y, Weber P, Long J, Liu J (2007) Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction. J Neurochem 103, 2690- 2700.
165. Rasbach KA, Schnellmann RG (2008) Isoflavones promote mitochondrial biogenesis. J Pharmacol Exp Ther 325, 536- 543.
166. Stites T, Storms D, Bauerly K, Mah J, Harris C, Fascetti A, Rogers Q, Tchaparian E, Satre M, Rucker RB (2006) Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice. J Nutr 136, 390-396.
167. Chowanadisai W, Bauerly KA, Tchaparian E, Wong A, Cortopassi GA, Rucker RB (2010) Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression. J Biol Chem 285, 142-152.
168. Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S, Moonen-Kornips E, Hesselink MK, Kunz I, Schrauwen-Hinderling VB, Blaak EE, Auwerx J, Schrauwen P, Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14, 612-622.
169. Guarente L (2008) Mitochondria-A nexus for aging, calorie restriction, and sirtuins? Cell 132, 171-176.
170. Civitarese AE, Carling S, Heilbronn LK, Hulver MH, Ukropcova B, Deutsch WA, Smith SR, Ravussin E (2007) Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PlosMed 4, e76.
171. Menshikova EV, Ritov VB, Fairfull L, Ferrell RE, Kelley DE, GoodpasterBH(2006) Effects of exercise on mitochondrial content and function in aging human skeletal muscle. J Gerontol A Biol Sci Med Sci 61, 534-540.
172. Johnston AP, De Lisio M, Parise G (2008) Resistance training, sarcopenia, and the mitochondrial theory of aging. Appl Physiol Nutr Metab 33, 191-199.